JUBLCPL

Jubilant Agri and Consumer Products Limited

Jubilant Agri and Consumer Products Limited (JUBLCPL) financial statements and selected valuation metrics through 30 June 2026.

Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals

jacpl.co.in(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹1854.40
Market cap
2,810 Cr
Stock P/E
21.6
P/B
6.14
ROE (FY26)
27.8%
ROCE (FY26)
36.6%
Operating margin (FY26)
9.4%
Debt / equity (FY26)
0.06
OCF / EBITDA (FY26)
38.2%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

JACPL (Jubilant Agri and Consumer Products) makes performance polymers and chemicals (such as SBR latex), adhesives, phosphatic fertilisers and agri nutrients, selling to industrial customers, consumers and farmers in India and export markets.

Company snapshot

31stBy market cap

Ranked among 68 companies in Specialty Chemicals.

Segment mix

Reportable segments as of 2024-12-31 (Consolidated). Revenue share = segment revenue ÷ total revenue.

Largest segment: 71.9% of revenue

SegmentRevenue shareRevenuePBTAssets
Agri Nutrients
1.1%
13 Cr5 Cr—
P&K Fertilizers
28.6%
333 Cr-3 Cr—
Performance Polymers & Chemicals
71.9%
836 Cr126 Cr—

Shares add up to 102% because segment revenues are before inter-segment eliminations.

What we see

Positives
  • ✓Debt-to-equity of 0.06x — the company is largely funded by its own money, not borrowed funds.
2 more signals from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricDec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales398 Cr398 Cr442 Cr513 Cr451 Cr485 Cr523 Cr
Operating expenses (approx.)363 Cr371 Cr380 Cr449 Cr412 Cr453 Cr455 Cr
EBITDA35 Cr27 Cr62 Cr64 Cr39 Cr33 Cr68 Cr
OPM %8.8%6.8%14.0%12.5%8.7%6.7%13.0%
Other income-0.20 Cr0.54 Cr2 Cr0.09 Cr0.19 Cr2 Cr0.83 Cr
Interest3 Cr2 Cr2 Cr1 Cr2 Cr2 Cr2 Cr
Depreciation4 Cr4 Cr4 Cr4 Cr5 Cr5 Cr5 Cr
Profit before tax28 Cr21 Cr58 Cr58 Cr29 Cr27 Cr62 Cr
Tax %23.1%24.6%24.2%27.6%25.8%25.0%25.1%
Net profit21 Cr16 Cr44 Cr42 Cr22 Cr20 Cr46 Cr
EPS (₹)₹14.16₹10.64₹29.29₹28.06₹14.20₹13.09₹30.43

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2025Mar 2026TTM
Sales1,561 Cr1,891 CrSign in free for the trailing twelve months
Operating expenses (approx.)1,415 Cr1,695 CrSign in free for the trailing twelve months
EBITDA146 Cr196 CrSign in free for the trailing twelve months
OPM %9.3%10.4%Sign in free for the trailing twelve months
Other income2 Cr4 CrSign in free for the trailing twelve months
Interest13 Cr7 CrSign in free for the trailing twelve months
Depreciation16 Cr18 CrSign in free for the trailing twelve months
Profit before tax117 Cr172 CrSign in free for the trailing twelve months
Tax %25.2%25.7%Sign in free for the trailing twelve months
Net profit88 Cr128 CrSign in free for the trailing twelve months
EPS (₹)₹58.25₹84.64Sign in free for the trailing twelve months
Dividend payout %0.0%0.0%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2025Mar 2026
Equity capital15 Cr15 Cr
Reserves310 Cr445 Cr
Borrowings56 Cr28 Cr
Other liabilities354 Cr448 Cr
Total liabilities735 Cr935 Cr
Fixed assets (net)180 Cr198 Cr
CWIP19 Cr27 Cr
Investments0.07 Cr0.06 Cr
Loans & advances0.11 Cr0.19 Cr
Inventories191 Cr215 Cr
Trade receivables287 Cr409 Cr
Cash & bank6 Cr6 Cr
Other assets52 Cr81 Cr
Total assets735 Cr935 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2025Mar 2026
Cash from operating activity129 Cr75 Cr
Cash from investing-35 Cr-39 Cr
Cash from financing-104 Cr-36 Cr
Net cash flow-9 Cr-0.24 Cr
Free cash flow (OCF − Capex)94 Cr35 Cr

Ratios

MetricMar 2025Mar 2026
ROCE %34.3%36.6%
ROE %27.0%27.8%
Debtor days6779
Inventory days8885
Days payable7684
Cash conversion cycle8080
OCF / EBITDA %88.8%38.2%
Debt / equity0.170.06
Current ratio1.461.63
Net debt / EBITDA0.340.11